EUVIMEDEUVIMED entdecken
Crossref

New Subependymal Enhancement After Radiation Therapy in High‐Grade Glioma: Utilizing Morphological Features and DSC Perfusion MRI in Differentiate Progression and Post‐Radiation Changes

Kyu Sung Choi iD, Inpyeong Hwang, Chul Kee Park iD, Sung Hye Park, Seung Hong Choi iD

Journal of Magnetic Resonance Imaging · 2025

DOI: 10.1002/jmri.29586 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2025. Verfasst von Kyu Sung Choi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Magnetic Resonance Imaging, Magnetic Resonance Angiography. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Research Foundation of Korea, Samsung, Institute for Basic Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The specific patterns of subependymal enhancement (SE) that frequently occur as radiation‐induced changes in high‐grade gliomas following radiotherapy are often overlooked. Perfusion MRI may offer a diagnostic clue.

Purpose

To distinguish between radiation‐induced SE and progression in adult high‐grade diffuse gliomas after standard treatment. Study Type Retrospective. Population Ninety‐four consecutive high‐grade diffuse glioma patients (mean age, 55 ± 14 years; 54 [57.4%] males) with new SE identified in follow‐up MRI after completion of surgery plus chemoradiation: progression (N = 74) vs. regression (N = 20). Field Strength/Sequence 3 T, gradient‐echo dynamic susceptibility contrast‐enhanced MRI, 3D gradient‐echo contrast‐enhanced T1‐weighted imaging. Assessment To differentiate between radiation changes and progression in SE evaluation, multivariable logistic regression was performed using significant variables among SE appearance interval, IDH mutation, morphological features, and rCBV. Cox regression was performed to predict the tumor progression. For the added value of the rCBV, a log‐rank test was conducted between the multivariable logistic regression models with and without the rCBV. Statistical Tests Logistic regression, Cox regression, receiver operating characteristic analysis, log‐rank test.

Results

38.3% (36/94) patients had first specific SE (9.2 ± 9.5 months after surgery), which disappeared in 21.3% (20/94) after 5.8 ± 5.8 months after initial appearance on post‐radiation MRI. IDH mutation, elongated, small lesions with lower rCBV tended to regress: IDH mutation, elongation, diameter, and rCBV_p95; odds ratio, 0.32, 1.92, 1.70, and 2.47, respectively. Qualitative evaluation of shape revealed that thin and curvilinear‐shaped SE tended to regress, indicating a significant correlation with quantitative shape features ( r = 0.31). In Cox regression, rCBV and lesion shape were significant (hazard ratio = 1.09 and 0.54, respectively). For sub‐centimeter lesions, the rCBV showed added value in predicting outcomes (area under the curve, 0.873 vs. 0.836; log‐rank test). Data Conclusion Smaller, elongated lesions with lower rCBV and IDH mutation are associated with regression when differentiating radiation changes from progression in high‐grade glioma with post‐radiotherapy SE. Evidence Level 3 Technical Efficacy Stage 2

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsMagnetic Resonance ImagingMagnetic Resonance AngiographyHumansMaleMiddle AgedFemaleRetrospective StudiesDisease ProgressionAdultAgedContrast MediaBrainNeoplasm GradingPerfusion Magnetic Resonance Imaging

Stichwörter der Autor:innen

glioblastomaleptomeningeal diseaseperfusion MRIradiation‐induced effectsubependymal enhancement

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Neurosurgery, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea.

ORCID-Profile: Kyu Sung Choi, Chul Kee Park, Seung Hong Choi

Förderung

  • National Research Foundation of Korea
  • Samsung
  • Institute for Basic Science
  • Seoul National University Hospital

Zitieren

APA

Choi, K. S., Hwang, I., Park, C. K., Park, S. H., & Choi, S. H. (2025). New Subependymal Enhancement After Radiation Therapy in High‐Grade Glioma: Utilizing Morphological Features and DSC Perfusion MRI in Differentiate Progression and Post‐Radiation Changes. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29586

Vancouver

Choi KS, Hwang I, Park CK, Park SH, Choi SH. New Subependymal Enhancement After Radiation Therapy in High‐Grade Glioma: Utilizing Morphological Features and DSC Perfusion MRI in Differentiate Progression and Post‐Radiation Changes. Journal of Magnetic Resonance Imaging. 2025. doi:10.1002/jmri.29586

BibTeX
@article{Choi2025,
  author = {Choi, Kyu Sung and Hwang, Inpyeong and Park, Chul Kee and Park, Sung Hye and Choi, Seung Hong},
  title = {New Subependymal Enhancement After Radiation Therapy in High‐Grade Glioma: Utilizing Morphological Features and DSC Perfusion MRI in Differentiate Progression and Post‐Radiation Changes},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2025},
  doi = {10.1002/jmri.29586}
}
Kostenlos starten →